Open AccessGonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial
Author(s) -
Daida Krishna,
Snehal Dhoble,
Praneesh Gautham,
R Suvarna,
Amit Upadhaya,
Kamini A Rao
Publication year - 2016
Publication title -
journal of human reproductive sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 31
eISSN - 0974-1208
pISSN - 1998-4766
DOI - 10.4103/0974-1208.192056
Subject(s) - ovarian hyperstimulation syndrome , in vitro fertilisation , human chorionic gonadotropin , polycystic ovary , medicine , gonadotropin releasing hormone agonist , gonadotropin releasing hormone antagonist , gynecology , controlled ovarian hyperstimulation , gonadotropin , embryo transfer , randomized controlled trial , gonadotropin releasing hormone , agonist , andrology , endocrinology , biology , pregnancy , hormone , luteinizing hormone , receptor , diabetes mellitus , insulin resistance , genetics
The objective of this study is to evaluate if gonadotropin-releasing hormone agonist (GnRHa) trigger is a better alternative to human chorionic gonadotropin (hCG) in polycystic ovary syndrome (PCOS) of Indian origin undergoing in vitro fertilization (IVF) cycles with GnRH antagonist for the prevention of ovarian hyperstimulation syndrome (OHSS).